Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) — Analysis Summary
Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) has a market cap of $245.01M with year-over-year revenue growth of -8.7%. Net margin stands at -53.1%. The stock trades at a P/E ratio of -3.0.
Key Takeaways
- Revenue changed -8.7% year-over-year
- Net margin of -53.1%
- P/E ratio of -3.0
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, ARCT posted revenue growth of -8.7% and trades at a P/E of -3.0.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.